Form 8-K - Current report:
SEC Accession No. 0001467154-22-000029
Filing Date
2022-03-11
Accepted
2022-03-11 07:04:35
Documents
14
Period of Report
2022-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20220311.htm   iXBRL 8-K 46112
2 EX-5.1 novn-8k031120222exhibit51.htm EX-5.1 19547
3 EX-10.1 novn-8k031120222exhibit101.htm EX-10.1 309237
  Complete submission text file 0001467154-22-000029.txt   578379

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20220311.xsd EX-101.SCH 1893
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20220311_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20220311_pre.xml EX-101.PRE 13037
8 EXTRACTED XBRL INSTANCE DOCUMENT novn-20220311_htm.xml XML 11371
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 22731099
SIC: 2834 Pharmaceutical Preparations